Reglagene is developing a first-in class, potent, orally available, blood-brain-barrier penetrant compound for high-grade glioma
Location: United States, Arizona, Tucson
Employees: 11-50
Founded date: 2016
Investors 1
Mentions in press and media 3
| Date | Title | Description | Source |
| 04.03.2024 | Reglagene Expands to Houston and Joins TMC's Accelerator for... | Reglagene's RGN6024 is on track to give new hope to provide orally administered therapy for brain ca... | einpresswi... |
| 04.01.2024 | REGLAGENE RECEIVES FDA ORPHAN DRUG DESIGNATION FOR INNOVATIV... | New therapy crosses blood-brain barrier to give new hope to patients with rare, aggressive cancer Th... | einpresswi... |
| 14.04.2022 | Pismo Ventures' National Life Science Startup Symposium Anno... | “This Symposium contained a seriously high-value cohort of Life Science Startups. This relatively ra... | prweb.com/... |